Diane Iler-Smith returned to Biolumina as senior VP, executive creative director. Iler-Smith has more than 20 years of strategic and creative leadership experience in healthcare communications, including extensive global and US branding and launch expertise. She leads all creative assignments at the agency.
Intouch Solutions continues to elevate employees across the agency.
I recently read an article about how awards do not really matter in the advertising industry. The author basically said the only thing advertising is supposed to do is sell stuff. I agree, but not completely. Awards do matter.
So what is leadership? I believe leadership consists of three components: commitment, integrity, and respect.
The U.S. regulatory landscape will continue to evolve in 2018, potentially adding complexity and compliance challenges to the life sciences industry. Recent changes are being driven by nationwide concerns with prescription drug abuse, which is prompting many states to enforce new mandates and programs regarding drug practices.
Two thirds, or 67 percent, of respondents have encountered lower turnover from direct hire sales reps as opposed to CSO reps, according to a recent survey of executives by Best Practices LLC.
As the landscape for pharmaceutical marketing continues to evolve, multi-channel marketers have been investigating opportunities to advertise their products and services, and provide clinical decision support information within electronic health records (EHRs). For the first time, healthcare marketers can impact provider-patient interactions by delivering messages directly at the point of care. EHRs have over 90 percent adoption with healthcare professionals (HCPs) in the U.S., while certain practice specialties reach nearly ubiquitous (99 percent) adoption, thereby creating an exceptional opportunity not to be missed!
Steve Sabus was named general manager of Astellas Pharma Canada (APCA), effective April 1, 2018. In his new role, he will lead business operations in the country.
Uwe Röhrhoff was named CEO of Perrigo Company following the retirement of John T. Hendrickson.
Timothy Whitten has become president of Taiho Oncology Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co. Ltd. (Japan).
Christopher O’Brien, M.D., chief medical officer of Neurocrine Biosciences Inc., retired in February 2018 after a transition period with his successor.
Shaun Urban was named president of the Inception Companies.
Wayne Swanton was promoted to executive VP, Global Operations, at Allergan Plc following notification that Rob Stewart, executive VP and chief operating officer, intended to leave Allergan to become president and CEO of Amneal Pharmaceuticals.
Anu Balendran, Ph.D., was appointed VP Business Development at Alligator Bioscience.
Michael Mulhern joined AMRI as CEO, succeeding William S. Marth.
CVS Health introduced Transform Rheumatoid Arthritis Care to help the company’s pharmacy benefit management clients better manage care and costs for rheumatoid arthritis. The program is the latest addition to the company’s suite of condition-specific, highly personalized Transform Care programs and adds value-based management strategies including outcomes-based contracts and a new indication-based formulary for autoimmune conditions to CVS Health’s integrated pharmacy care model
As part of its CareCentered Contracting program, pharmacy benefit manager Prime Therapeutics LLC entered into an outcomes-based contract with Boehringer Ingelheim for Jardiance, an oral type 2 diabetes medicine indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
Shares of Pacira Pharmaceuticals plunged more than 15 percent after the company revealed a U.S. Food and Drug Administration advisory panel recommended against approving expanded use of the company’s pain treatment Exparel.
With a high-profile group of investors and backers, Celgene Corp. spinout Celularity launched with $250 million.
Two Swiss freestyle skiers were the first athletes confirmed to have been hit by a highly contagious virus that causes vomiting and diarrhea at the Pyeongchang Winter Games, the Swiss Olympic team confirmed on Friday.